Profil
David Nakasone is Senior Director-Investor Relations at Tarsus Pharmaceuticals, Inc. since 2021.
Formerly, Mr. Nakasone was Director-Investor Relations at Lineage Cell Therapeutics, Inc., Associate Director-Investor Relations at Ionis Pharmaceuticals, Inc., and Investor Relations Contact at Allergan, Inc. from 2013 to 2015.
Education includes undergraduate studies at San Diego State University.
Postes actifs de David Nakasone
| Sociétés | Poste | Début |
|---|---|---|
| TARSUS PHARMACEUTICALS, INC. | Investor Relations Contact | 01/09/2021 |
Anciens postes connus de David Nakasone
| Sociétés | Poste | Fin |
|---|---|---|
| ALLERGAN, INC. | Public Communications Contact | 01/06/2015 |
| IONIS PHARMACEUTICALS, INC. | Public Communications Contact | - |
| LINEAGE CELL THERAPEUTICS, INC. | Investor Relations Contact | - |
Formation de David Nakasone
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapeutic drugs for blepharitis | Health Technology |
















